Circulating RBP4 levels were not significantly different between obese patients and normal weight subjects but were significantly elevated in hypertensive patients compared with normotensive subjects, consistent with our previous study [25], which revealed that RBP4 possibly involved in pathogenesis of hypertension, not obesity. Here, RBP4 is linked to obesity due to melanocortin 4 receptor deficiency.